AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
-1.38%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$97.1B
AUM Growth
+$19.4B
(+25%)
Cap. Flow
+$22.6B
Cap. Flow
% of AUM
23.3%
Top 10 Holdings %
Top 10 Hldgs %
12.02%
Holding
3,234
New
373
Increased
1,829
Reduced
905
Closed
84
Top Buys
| 1 |
General Motors
GM
|
+$374M |
| 2 |
Snowflake
SNOW
|
+$354M |
| 3 |
Arista Networks
ANET
|
+$354M |
| 4 |
Roblox
RBLX
|
+$345M |
| 5 |
Adobe
ADBE
|
+$332M |
Top Sells
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$173M |
| 2 |
Progressive
PGR
|
+$169M |
| 3 |
AbbVie
ABBV
|
+$139M |
| 4 |
Robinhood
HOOD
|
+$132M |
| 5 |
Cardinal Health
CAH
|
+$123M |
Sector Composition
| 1 | Technology | 22.14% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 11.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
X4 Pharmaceuticals
XFOR
$71.2M
| $20.6K | ﹤0.01% |
2,899
+2,004
| +224% | +$14.2K |
|
3127
Navitas Semiconductor
NVTS
$1.23B
| $20.5K | ﹤0.01% |
+10,019
| New | +$20.5K |
|
3128
Plug Power
PLUG
$1.64B
| $19.9K | ﹤0.01% |
+15,232
| New | +$19.9K |
|
3129
Stereotaxis
STXS
$262M
| $19.8K | ﹤0.01% |
+11,234
| New | +$19.8K |
|
3130
Lightwave Logic
LWLG
$413M
| $19.4K | ﹤0.01% |
+18,957
| New | +$19.4K |
|
3131
Nautilus Biotechnolgy
NAUT
$85.3M
| $18.5K | ﹤0.01% |
+21,442
| New | +$18.5K |
|
3132
Skye Bioscience
SKYE
$129M
| $17.9K | ﹤0.01% |
11,251
-10,402
| -48% | -$16.5K |
|
3133
FiscalNote
NOTE
$67.8M
| $16.1K | ﹤0.01% |
1,662
-42
| -2% | -$407 |
|
|
EU
3134
enCore Energy
EU
$425M
| $16.1K | ﹤0.01% |
+11,724
| New | +$16.1K |
|
|
ELEV
3135
DELISTED
Elevation Oncology
ELEV
| $14.9K | ﹤0.01% |
+57,530
| New | +$14.9K |
|
3136
Lineage Cell Therapeutics
LCTX
$288M
| $14.4K | ﹤0.01% |
+31,991
| New | +$14.4K |
|
3137
Galectin Therapeutics
GALT
$307M
| $14.1K | ﹤0.01% |
+11,582
| New | +$14.1K |
|
3138
Solid Power
SLDP
$673M
| $14.1K | ﹤0.01% |
+13,420
| New | +$14.1K |
|
3139
Harvard Bioscience
HBIO
$19.6M
| $12.9K | ﹤0.01% |
+22,780
| New | +$12.9K |
|
3140
Pacific Biosciences
PACB
$375M
| $12.9K | ﹤0.01% |
+10,922
| New | +$12.9K |
|
3141
Rekor Systems
REKR
$136M
| $12.8K | ﹤0.01% |
+14,380
| New | +$12.8K |
|
3142
LiveOne
LVO
$56.3M
| $11.9K | ﹤0.01% |
+17,002
| New | +$11.9K |
|
3143
Atossa Therapeutics
ATOS
$104M
| $10.9K | ﹤0.01% |
+16,240
| New | +$10.9K |
|
3144
Renovaro
RENB
$44.5M
| $10.9K | ﹤0.01% |
20,004
+9,517
| +91% | +$5.17K |
|
3145
System1
SST
$62.8M
| $10.7K | ﹤0.01% |
2,802
+975
| +53% | +$3.72K |
|
3146
Veru
VERU
$49.4M
| $8.81K | ﹤0.01% |
+1,798
| New | +$8.81K |
|
3147
Lyra Therapeutics
LYRA
$10.8M
| $7.33K | ﹤0.01% |
1,161
+587
| +102% | +$3.71K |
|
|
SBDS
3148
Solo Brands, Inc.
SBDS
$22M
| $5.53K | ﹤0.01% |
32,958
-267,358
| -89% | -$44.9K |
|
3149
Ovid Therapeutics
OVID
$88.9M
| $4.82K | ﹤0.01% |
15,450
+4,811
| +45% | +$1.5K |
|
3150
Solidion Technology
STI
$15.3M
| $2.44K | ﹤0.01% |
+405
| New | +$2.44K |
|